TABLE 1

Clinical, Imaging, and Follow-up Patient Data

Patient no.	Age (y)	Sex	Histologic type	pStage	Size (cm)	MRS			¹⁸F-FDG (SUV)	Postoperative recurrence	Survival interval (mo)		Status
Patient no.	Age (y)	Sex	Histologic type	pStage	Size (cm)				¹⁸F-FDG (SUV)	Postoperative recurrence			Status	R_lac	R_cho	Disease-free	Overall
1	60	F	BAC	IA	1.6	1.6	1.3	1.85	−	45	45	Alive
2	66	M	BAC	IB	4.0	1.1	1.0	2.14	−	34	34	Alive
3	59	F	BAC	IA	2.2	0.9	0.9	1.20	−	48	48	Alive
4	69	F	BAC	IB	3.8	1.2	2.6	2.78	−	37	37	Alive
5	76	F	BAC	IA	2.0	3.3	4.0	1.32	−	50	50	Alive
6	73	F	BAC	IA	2.8	1.1	2.0	2.31	−	31	31	Alive
7	61	F	WDA	IA	2.0	1.5	1.9	1.24	−	18	18	Alive
8	65	M	WDA	IA	2.8	0.5	1.9	1.79	−	34	34	Alive
9	48	F	WDA	IA	2.0	3.3	2.9	1.78	−	31	31	Alive
10	78	F	WDA	IA	2.0	2.1	3.0	1.21	−	23	23	Alive
11	65	F	WDA	IA	2.6	3.2	6.1	1.91	−	35	35	Alive
12	64	F	WDA	IA	3.0	0.6	2.4	3.25	−	2	2	Alive
13	74	M	MDA	IA	1.8	0.4	0.6	2.52	+	2	4	Deceased
14	64	M	MDA	IIIB	3.6	2.0	2.5	5.94	+	21	36	Deceased
15	69	M	MDA	IIIA	3.8	1.9	1.8	4.87	+	8	10	Deceased
16	60	F	MDA	IIIA	3.5	2.6	4.4	7.06	+	14	19	Deceased
17	50	M	PDA	IB	5.2	1.0	1.8	5.02	+	30	46	Deceased
18	54	M	PDA	IIIA	4.0	3.5	4.0	8.29	+	4	5	Deceased
19	73	M	PDA	IIA	2.7	1.1	3.0	8.05	+	38	45	Alive

pStage = pathologic stage; disease-free = time from date of operation until recurrence or the last follow-up date; overall = time from date of operation until death or the last follow-up date; BAC = bronchioloalveolar carcinoma; WDA = well-differentiated adenocarcinoma; MDA = moderately differentiated adenocarcinoma; PDA = poorly differentiated adenocarcinoma.